HyperRab (Rabies Immune Globulin-Human) (SD Viral Inactivated) should not be administered IV because of the potential for serious reactions. Although systemic reactions to immunoglobulin preparations are rare, epinephrine should be available for treatment of acute anaphylactic symptoms.
Use in pregnancy: Pregnancy Category C: Animal reproduction studies have not been conducted with HyperRab (Rabies Immune Globulin-Human) (SD Viral Inactivated). It is also not known whether it can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. It should be given to a pregnant woman only if clearly needed.
Use in children: Safety and effectiveness in the pediatric population have not been established.